General Catalyst Group Management’s ArriVent BioPharma AVBP Stock Holding History

General Catalyst Group Management’s Portfolio AVBP Stock Details AVBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$32.5M	Hold
2025 Q1	$27.6M	Hold
2024 Q4	$39.8M	Hold
2024 Q3	$35.1M	Hold
2024 Q2	$27.7M	Hold
2024 Q1	$26.7M	Buy